The Oncotype DX Breast Recurrence Score® test can provide personalized insights for certain people with breast cancer, whose cancer is:​ Stage I, II, or IIIa​ HR+​ HER2-​ Each patient receives an individualized score to help them make more informed treatment choices.​ Learn more about the Oncotype DX® test: bit.ly/3AXOiBE | Until Everyone Knows | Facebook

The Oncotype DX Breast Recurrence Score® test can help predict the chemotherapy benefit of a person with #BreastCancer.*​ Specifically, the test is for stage I-IIIA hormone receptor-positive, HER2-negative breast cancer. ​ Learn more about the Oncotype DX® test: https://bit.ly/41Js3Kr #CancerTreatment #CancerCare​ *Paik et al. J Clin Oncol. 2006;24(23):3726-3734; Albain et al. Lancet Oncol. 2010;11(1):55-65 | Until Everyone Knows | Facebook

67 reactions · 28 shares | The Oncotype DX Breast Recurrence Score®...

5.1K views · 261 reactions | Watch our Facebook Live now! Listen as FORCE founder Sue Friedman and Oncotype DX® patient ambassador Punita K. talk about why advocating for yourself while navigating cancer matters and how genomic and genetic tests can help. | Exact Sciences | Facebook

6.2K views · 43 reactions | Dr. Merle Sogge, chief of gastroenterology at Kaiser Modesto Medical Center, gives a 360-degree tour on Thursday of an inflatable colon that was displayed at the hospital on Dale Road. March is Colorectal Cancer Awareness Month, and Sogge was showing what doctors look for and discussing the importance of having your colon checked. Kaiser Permanente of Modesto Kaiser Permanente Hospital | The Modesto Bee | Facebook